Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Osama Roshdy"'
Autor:
Åse Bratland, Eva Munoz-Couselo, Laurent Mortier, Osama Roshdy, Rene González, Jacob Schachter, Ana M. Arance, Florent Grange, Nicolas Meyer, Abhishek Jagdish Joshi, Salem Billan, Brett G. M. Hughes, Jean-Jacques Grob, Karthik Ramakrishnan, Joy Ge, Burak Gumuscu, Ramona F. Swaby, Ralf Gutzmer
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 12, Pp 3165-3180 (2023)
Abstract Introduction At first interim analysis of KEYNOTE-629, health-related quality of life (HRQoL) with pembrolizumab was stable or improved over 48 weeks in recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC). HRQoL results fr
Externí odkaz:
https://doaj.org/article/c25ae9485a674062bd066049630a8b43
Autor:
Wilson H Miller, Khashayar Esfahani, Meagan-Helen Henderson Berg, Hanieh Zargham, Robin Billick, Kevin Pehr, Margaret Redpath, Osama Roshdy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Treatment with programmed cell death 1 inhibitors is associated with a wide range of cutaneous immune-related adverse events, with lichenoid eruptions representing one of the major cutaneous toxicities. We describe the case of an 81-year-old man with
Externí odkaz:
https://doaj.org/article/c193968ca5ea4091b0f9870ec417d584
Autor:
Abdelaziz, Ghada Abdelaziz Mohamed1 ghadaabdalzizo@gmail.com, Elsafi, Osama Roshdy1, Fattah, Nelly R. Abdel2, Abdelazeem, Mahmoud1
Publikováno v:
Egyptian Journal of Hospital Medicine. Jan2023, Vol. 90 Issue 2, p2526-2533. 8p.
Autor:
Elsafy, Osama Roshdy1, Mohamed, Marwa Zakaria1, El Fattah, Nermin Raafat Abd2, Elgohary, Nehal Tarek Anwer3 crazynonna89@gmail.com
Publikováno v:
Zagazig University Medical Journal. Jan2023, Vol. 29 Issue 1, p155-160. 6p.
Autor:
Ghada Abdelaziz Mohamed Abdelaziz, Osama Roshdy Elsafi, Nelly R. Abdel Fattah, Mahmoud Abdelazeem
Publikováno v:
The Egyptian Journal of Hospital Medicine. 90:2526-2533
Autor:
Elham Rahme, Andrei Zubarev, Mathieu Powell, Elena Netchiporouk, Gizelle Popradi, Ivan V. Litvinov, Feras M. Ghazawi, Steven J. Glassman, Akram Alakel, Osama Roshdy, Linda Moreau, Michelle Le, Denis Sasseville
Publikováno v:
Current Oncology
Volume 26
Issue 4
Pages 4625-481
Volume 26
Issue 4
Pages 4625-481
Follicular lymphoma (fl) is the most common indolent lymphoma and the 2nd most common non-Hodgkin lymphoma, accounting for 10%&ndash
20% of all lymphomas in the Western world. Epidemiologic and geographic trends of fl in Canada have not been inv
20% of all lymphomas in the Western world. Epidemiologic and geographic trends of fl in Canada have not been inv
Autor:
Simon F. Roy, Osama Roshdy, François Lagacé, Andrei Zubarev, Michelle Le, Janelle Cyr, Steven J. Glassman, Elham Rahme, Denis Sasseville, Feras M. Ghazawi, Elena Netchiporouk, Nebras Alghazawi, Ivan V. Litvinov
Publikováno v:
Journal of Cutaneous Medicine and Surgery. 23:394-412
Background: We recently reported a steady increase in the incidence and mortality of cutaneous malignant melanoma (CMM) in Canada during 1992-2010. Objectives: The objective of this article is to examine the distribution of Canadian CMM patients at t
Autor:
Linda Moreau, Michelle Le, Gizelle Popradi, Denis Sasseville, Janelle Cyr, Elham Rahme, Steven J. Glassman, Elena Netchiporouk, Feras M. Ghazawi, Akram Alakel, François Lagacé, Matthew Tsang, Andrei Zubarev, Ivan V. Litvinov, Osama Roshdy
Publikováno v:
Cancer. 125:2435-2444
Background Multiple myeloma (MM) is a malignancy of mature plasma cells. Environmental risk factors identified for this malignancy, among others, include farming and exposure to pesticides. Methods Using 3 independent population-based databases (the
Publikováno v:
Clinical Case Reports
Key Clinical Message Idiopathic Atrophoderma of Pasini and Pierini should be considered on the differential in a patient presenting with an asymptomatic atrophic plaque on the skin. Differentiation from Linear Atrophoderma of Moulin and morphea remai
Autor:
Eva Muñoz-Couselo, Osama Roshdy, Salem Billan, Nicolas Meyer, P. Zhang, Abhishek Joshi, Florent Grange, R. Gonzalez Mendoza, Laurent Mortier, J.-J. Grob, A. Arance, Burak Gumuscu, Brett G.M. Hughes, R. Gutzmer, Jacob Schachter, Åse Bratland, Ramona F. Swaby
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 32(10)
Background Pembrolizumab demonstrated clinically meaningful and durable antitumor activity with a manageable safety profile in recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC). Patients and methods KEYNOTE-629 was a global, open-la